ASTRAZENECA PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge
SEC filing record 1 source field available
Fiscal year end
31 December
ASTRAZENECA PLC has filed 2,049 SEC EDGAR filings since 13 Mar 1995

SEC filing history

Showing 751-775 of 1,000 matching filings.

Per page
25
Current page
31
6-K File 001-11960

CALQUENCE APPROVED IN JAPAN FOR CLL

Filing date
25 Jan 2021
Reporting date
25 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

CALQUENCE MET PRIMARY EFFICACY ENDPOINT IN HEAD-TO-HEAD TRIAL AGAINST IBRUTINIB

Filing date
25 Jan 2021
Reporting date
25 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ENHERTU APPROVED IN THE EU FOR BREAST CANCER

Filing date
20 Jan 2021
Reporting date
20 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ENHERTU APPROVED IN THE US FOR GASTRIC CANCER

Filing date
19 Jan 2021
Reporting date
19 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

IMFINZI APPROVED IN THE EU FOR LESS-FREQUENT, FIXED- DOSE USE IN UNRESECTABLE NO

Filing date
15 Jan 2021
Reporting date
15 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FARXIGA GRANTED PRIORITY REVIEW IN THE US FOR THE TREATMENT OF PATIENTS WITH CHR

Filing date
06 Jan 2021
Reporting date
06 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
04 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ATACAND DIVESTMENT TO CHEPLAPHARM IN MORE THAN 70 COUNTRIES COMPLETED

Filing date
04 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA'S COVID-19 VACCINE AUTHORISED IN UK

Filing date
30 Dec 2020
Reporting date
30 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

LYNPARZA APPROVED IN JAPAN FOR THE TREATMENT OF ADVANCED OVARIAN, PROSTATE AND P

Filing date
29 Dec 2020
Reporting date
29 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TAGRISSO APPROVED IN THE US FOR THE ADJUVANT TREATMENT OF PATIENTS WITH EARLY-ST

Filing date
21 Dec 2020
Reporting date
21 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

UPDATE ON US REGULATORY REVIEW OF ROXADUSTAT IN ANAEMIA OF CHRONIC KIDNEY DISEAS

Filing date
21 Dec 2020
Reporting date
21 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
18 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
17 Dec 2020
Reporting date
17 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
17 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
16 Dec 2020
Reporting date
16 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
15 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

IMFINZI NEW DOSE RECEIVES POSITIVE EU CHMP OPINION

Filing date
15 Dec 2020
Reporting date
15 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
14 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
14 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
14 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
14 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TRASTUZUMAB DERUXTECAN POSITIVE CHMP

Filing date
14 Dec 2020
Reporting date
14 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TRIXEO AEROSPHERE APPROVED IN THE EU FOR COPD

Filing date
14 Dec 2020
Reporting date
14 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA TO ACQUIRE ALEXION PHARMACEUTICALS INC

Filing date
14 Dec 2020
Reporting date
14 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .